Advanced search
Publication Cover
Clinical Toxicology Volume 52, 2014 - Issue 3
Submit an article Journal homepage
371
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice

P. I. DarganClinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK;King's College London, London, UKCorrespondence[email protected]
,
H. C. TangBrain Research Centre, Institute of Chinese Medicine, Chinese University of Hong Kong, Hong Kong
,
W. LiangBrain Research Centre, Institute of Chinese Medicine, Chinese University of Hong Kong, Hong Kong
,
D. M. WoodClinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK;King's College London, London, UK
&
D. T. YewBrain Research Centre, Institute of Chinese Medicine, Chinese University of Hong Kong, Hong Kong
Pages 176-180 | Received 17 Dec 2013, Accepted 04 Feb 2014, Published online: 28 Feb 2014

Citations (46)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nabi Javadi, Mojtaba Rezaeian & Hossein Fakhraian. (2021) The conglomerate crystal formation of methoxetamine salts in the presence of some organic achiral anions: a theoretical approach. Supramolecular Chemistry 33:5, pages 183-193.
Read now
Will Lawn, Rohan Borschmann, Angela Cottrell & Adam Winstock. (2016) Methoxetamine: prevalence of use in the USA and UK and associated urinary problems. Journal of Substance Use 21:2, pages 115-120.
Read now

Articles from other publishers (44)

João P. Silva, Helena Carmo & Félix Carvalho. (2022) Drugs of abuse and kidney toxicity. Current Opinion in Toxicology 32, pages 100360.
Crossref
Rie Tanaka, Maiko Kawamura, Sakumi Mizutani, Takashi Hakamatsuka & Ruri Kikura-Hanajiri. (2022) Identification of Three Arylcyclohexylamines (MXPr, MXiPr, and DMXE) in Illegal Products危険ドラッグ製品中のarylcyclohexylamine誘導体，MXPr, MXiPr, DMXEの同定. YAKUGAKU ZASSHI 142:6, pages 675-681.
Crossref
Bronislav Jurásek, Silvie Rimpelová, Martin Babor, Jan Čejka, Vilém Bartůněk & Martin Kuchař. (2022) Intriguing Cytotoxicity of the Street Dissociative Anesthetic Methoxphenidine: Unexpected Impurities Spotted. International Journal of Molecular Sciences 23:4, pages 2083.
Crossref
Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 381 414 .
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland & Fabrizio Schifano. (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019. Journal of Psychopharmacology 35:11, pages 1324-1348.
Crossref
Matteo Marti, Giuseppe Talani, Cristina Miliano, Sabrine Bilel, Francesca Biggio, Jessica Bratzu, Marco Diana, Maria Antonietta De Luca & Liana Fattore. (2021) New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology 345, pages 113836.
Crossref
Tomohiko Irie, Daiju Yamazaki & Ruri Kikura-Hanajiri. (2021) A potential of methoxpropamine to be a widespread recreational drug: it blocks NMDA receptors and inhibits NMDA receptor-mediated synaptic transmission in a brain preparation of mice. Forensic Toxicology 39:2, pages 474-480.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Raquel Santos‐Toscano, Amira Guirguis & Colin Davidson. (2020) How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe. British Journal of Clinical Pharmacology 86:3, pages 452-481.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Martin Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum & Alessandro Vento. (2019) New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues. Current Addiction Reports 6:2, pages 140-152.
Crossref
Chrislean Jun Botanas, June Bryan de la Peña, Hee Jin Kim, Yong Sup Lee & Jae Hoon Cheong. (2019) Methoxetamine: A foe or friend?. Neurochemistry International 122, pages 1-7.
Crossref
Abdulsallam Bakdash, Ahmad Mohamed Khir AL-Mathloum, Elkhatim H. Abdelgadir ElAmin, Nael M. T. Abu Taha, Sachil Kumar & Fahd Ali Nasr. (2018) Single-dose acute toxicity of THJ-2201 designer Cannabis drug: LD50 and hematological and histological changes in mice. Egyptian Journal of Forensic Sciences 8:1.
Crossref
James H. Ho & Paul I. Dargan. 2018. Critical Care Toxicology. Critical Care Toxicology 1 47 .
Jason Wallach & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances 305 352 .
Laura Hondebrink, Emma E.J. Kasteel, Anke M. Tukker, Fiona M.J. Wijnolts, Anouk H.A. Verboven & Remco H.S. Westerink. (2017) Neuropharmacological characterization of the new psychoactive substance methoxetamine. Neuropharmacology 123, pages 1-9.
Crossref
Mariah Kincaid Tanious, Sascha S. Beutler, Alan D. Kaye & Richard D. Urman. (2017) New Hypnotic Drug Development and Pharmacologic Considerations for Clinical Anesthesia. Anesthesiology Clinics 35:2, pages e95-e113.
Crossref
Hoi Cheung, Tony Chow & David Yew. (2017) How Ketamine Affects Livers of Pregnant Mice and Developing Mice?. International Journal of Molecular Sciences 18:5, pages 1098.
Crossref
Qiang Wang, Qinghui Wu, Junpeng Wang, Yang Chen, Guihao Zhang, Jiawei Chen, Jie Zhao & Peng Wu. (2017) Ketamine Analog Methoxetamine Induced Inflammation and Dysfunction of Bladder in Rats. International Journal of Molecular Sciences 18:1, pages 117.
Crossref
B. Jurasek, M. Himl, R. Jurok, K. Hajkova, A. Vobinuskova, P. Rezanka & M. Kuchar. (2017) Synthesis of methoxetamine, its metabolites and deuterium labelled analog as analytical standards and their HPLC and chiral capillary electrophoresis separation. RSC Advances 7:89, pages 56691-56696.
Crossref
Joshua D. King. 2017. Critical Care Toxicology. Critical Care Toxicology 409 423 .
James H. Ho & Paul I. Dargan. 2017. Critical Care Toxicology. Critical Care Toxicology 1439 1484 .
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine 35 46 .
Mary T. Zanda, Paola Fadda, Cristiano Chiamulera, Walter Fratta & Liana Fattore. (2016) Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Behavioural Pharmacology 27:6, pages 489-496.
Crossref
Kevin F. Maskell, Michael L. Bailey & S. Rutherfoord Rose. (2016) Self Medication with Methoxetamine as an Analgesic Resulting in Significant Toxicity. Pain Medicine 17:9, pages 1773-1775.
Crossref
Rachel R. Horsley, Eva Lhotkova, Katerina Hajkova, Bronislav Jurasek, Martin Kuchar & Tomas Palenicek. (2016) Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat. Brain Research Bulletin 126, pages 102-110.
Crossref
Hsin‐Yi Shyu, Chun‐Jung Ko, Yu‐Chen Luo, Hsin‐Ying Lin, Shang‐Ru Wu, Shao‐Wei Lan, Tai‐Shan Cheng, Shih‐Hsiung Hu & Ming‐Shyue Lee. (2015) Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK‐3β‐Dependent Mechanism. Journal of Cellular Biochemistry 117:4, pages 881-893.
Crossref
Adam R. Winstock, Will Lawn, Paolo Deluca & Rohan Borschmann. (2016) Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review 35:2, pages 212-217.
Crossref
Joshua D. King. 2016. Critical Care Toxicology. Critical Care Toxicology 1 15 .
James H. Ho & Paul I. Dargan. 2016. Critical Care Toxicology. Critical Care Toxicology 1 46 .
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition 697 754 .
Kathleen S Bonnici, Paul I Dargan & David M Wood. (2015) Novel psychoactive substances or ‘legal highs'. British Journal of Hospital Medicine 76:9, pages C130-C134.
Crossref
R. Giorgetti, D. Marcotulli, A. Tagliabracci & F. Schifano. (2015) Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability. Forensic Science International 252, pages 127-142.
Crossref
Agnieszka Wiesner, Aleksandra Tyl & Jolanta B. Zawilska. (2015) Metoksetamina – nowy związek psychoaktywny („dopalacz”) o silnym działaniu psychodysleptycznym. Alcoholism and Drug Addiction 28:2, pages 131-138.
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Laurent Karila, Bruno Megarbane, Lucie Chevillard, Nadia Benturquia, Jean-Louis Laplanche & Michel Lejoyeux. (2015) Nouveaux produits de synthèse : revue des données actuelles. La Presse Médicale 44:4, pages 383-391.
Crossref
. 2015. Ketamine. Ketamine 118 159 .
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) New Synthetic Drugs in Addictovigilance. Therapies 70:2, pages 179-189.
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) Nouvelles drogues de synthèse en addictovigilance. Therapies 70:2, pages 167-178.
Crossref
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti & John M. Corkery. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:1, pages 15-26.
Crossref
Sheng-Nan Wu, Hui-Zhen Chen, Yu-Hung Chou, Yan-Ming Huang & Yi-Ching Lo. (2015) Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin–Darby canine kidney cells. Toxicology Reports 2, pages 1182-1193.
Crossref
Jolanta B. Zawilska. (2014) Methoxetamine – a novel recreational drug with potent hallucinogenic properties. Toxicology Letters 230:3, pages 402-407.
Crossref
Raymond J.M. Niesink & Tibor M. Brunt. (2015) Dissociatieve anesthesie: van ‘angel dust’ tot methoxetamine. Verslaving 11:4, pages 261-271.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.